Additional details reconciling the selected GAAP financial measure to the selected non-GAAP financial measure may be found in the "Schedule Reconciling Selected Non-GAAP Financial Measures to Comparable GAAP Financial Measures" and "Notes Reconciling Non-GAAP Financial Information to GAAP Financial Information".
MICROSEMI CORPORATION | ||||||||||||
Consolidated Condensed Statement of Income and Operating Cash Flow | ||||||||||||
(unaudited, in millions, except per share amounts) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended | ||||||||||
|
|
Dec 30,
|
|
Sep 30,
|
|
Jan 1,
| ||||||
Net sales |
|
$ |
247.6 |
|
$ |
263.1 |
|
$ |
240.9 | |||
Cost of sales |
|
105.0 |
|
112.7 |
|
115.2 | ||||||
Gross profit |
|
$ |
142.6 |
|
$ |
150.4 |
|
$ |
125.7 | |||
|
|
|
|
|
|
| ||||||
Operating expenses |
|
|
|
|
|
| ||||||
Selling, general and administrative |
|
$ |
51.3 |
|
$ |
53.6 |
|
$ |
48.6 | |||
Research and development |
|
43.2 |
|
42.8 |
|
39.6 | ||||||
Amortization of intangible assets |
|
21.7 |
|
27.4 |
|
24.9 | ||||||
Acquisition costs |
|
— |
|
0.5 |
|
6.1 | ||||||
Restructuring charges |
|
0.9 |
|
(0.5) |
|
7.2 | ||||||
Total operating expenses |
|
$ |
117.1 |
|
$ |
123.8 |
|
$ |
126.4 | |||
|
|
|
|
|
|
| ||||||
Operating income (loss) |
|
$ |
25.5 |
|
$ |
26.6 |
|
$ |
(0.7) | |||
|
|
|
|
|
|
| ||||||
Interest and other (expense), net |
|
(8.3) |
|
(8.6) |
|
(44.2) | ||||||
Income (loss) before income taxes |
|
$ |
17.2 |
|
$ |
18.0 |
|
$ |
(44.9) | |||
Provision (benefit) for income taxes |
|
3.0 |
|
6.4 |
|
(0.3) | ||||||
Net income (loss) |
|
$ |
14.2 |
|
$ |
11.6 |
|
$ |
(44.6) | |||
|
|
|
|
|
|
| ||||||
Earnings (loss) per share |
|
|
|
|
|
| ||||||
Basic |
|
$ |
0.16 |
|
$ |
0.13 |
|
$ |
(0.52) | |||
Diluted |
|
$ |
0.16 |
|
$ |
0.13 |
|
$ |
(0.52) | |||
|
|
|
|
|
|
| ||||||
Weighted-average common shares outstanding |
|
|
|
|
|
| ||||||
Basic |
|
88.5 |
|
86.5 |
|
85.2 | ||||||
Diluted |
|
90.1 |
|
88.8 |
|
85.2 | ||||||
|
|
|
|
|
|
| ||||||
Operating cash flow |
|
$ |
28.1 |
|
$ |
55.2 |
|
$ |
19.2 | |||
Capital expenditures |
|
(8.5) |
|
(9.3) |
|
(12.4) | ||||||
Free cash flow |
|
$ |
19.6 |
|
$ |
45.9 |
|
$ |
6.8 |